viewInnovaDerma PLC

InnovaDerma PLC - Notice of Results and Presentation

RNS Number : 3599Z
InnovaDerma PLC
18 September 2020

  LEI: 213800WRAP6W8VDL6B38

InnovaDerma PLC

("InnovaDerma" or the "Company")

Notice of Results

InnovaDerma (LSE: IDP), a UK developer of beauty, personal care and life sciences products, will announce its full year results for the year ended 30 June 2020 on Wednesday, 30 September 2020.

The management of InnovaDerma will deliver an online results presentation open to all existing and potential investors via the Investor Meet Company platform on Wednesday, 30 September 2020 at 9am UK time.


Investors can sign up for free via: https://www.investormeetcompany.com/innovaderma-plc/register-investor


Investors who have already registered and added to meet the Company will be automatically invited.

The presentation is in line with InnovaDerma's commitment to ensuring appropriate communication structures are in place for all sections of its shareholder base so that its strategy, business model and performance are clearly understood.  


Questions can be submitted pre-event through the platform or at any time during the live presentation.  Management may not be in a position to answer every question it receives but will address those it can while remaining within the confines of information already disclosed to the market. Responses to the Q&A from the live presentation will be published at the earliest opportunity on the Investor Meet Company platform.


Investor feedback can also be submitted directly to management post-event to ensure the Company can understand the views of all elements of its shareholder base.




Further enquiries


Joe Bayer





+61 (0)3 9863 8030

+44 (0)20 7930 0777

finnCap Ltd

Geoff Nash/ Kate Bannatyne

Alice Lane/Manasa Patil - Corporate Broking



+44 (0)207 220 0500


TB Cardew

Shan Shan Willenbrock/Tom Allison

Olivia Rosser


+ 44 (0)20 7930 0777

[email protected]




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

Quick facts: InnovaDerma PLC

Price: 52.5

Market: LSE
Market Cap: £7.61 m

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Morning report: FTSE flies as HSBC jumps and Trump tax evasion accusation...

FTSE 100 made a decent start to the week buoyed by M&A activity and good rises by markets in Asia. The blue chip index was up 90 at 5,933. Donald Trump paid just US$750 in tax in 2016 and 2017 and none at all for a decade, according to The New York Times. Trump, who said the report was...

3 weeks, 5 days ago

3 min read